Customised colorectal cancer early diagnosis programme can identify advanced adenomas and early-stage cancer
Dr Mirjam Crul, Vice-President of the European Society of Oncology Pharmacy (ESOP), speaks to ecancer about ECO’s ‘Time To Act’ campaign. She initially explains the background of this campaign.
Dr Crul states that a combined European effort is needed to ensure cancer doesn’t become forgotten during the pandemic, and a deeper long-term European health cooperation is sustained.
In the end, she talks about the future goals of ECO regarding the pandemic and cancer.
Customised colorectal cancer early diagnosis programme can identify advanced adenomas and early-stage cancer
Empowering cancer care in Africa
The added value of integrative medicine
Gaza's cancer patients: Navigating the dual struggle of illness and war
Cancer in emergencies: What can we do better to protect the most vulnerable?
Tele-mentoring: Impact of project ECHO
Powering equity in cancer care through digital health
Grand Rounds: Improving quality of patient-centred care
Genomic testing: Awareness and effective communication between healthcare professionals and patients